This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

CSM recommendations

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Prolonged use of cyproterone may produce dose-related hepatotoxicity. Effects include:

  • hepatitis
  • cholestatic jaundice
  • hepatic failure
  • death

The Committee on the Safety of Medicine recommend that:

  • long-term daily doses of 300 mg be restricted to:
    • short courses to cover the effects of LHRH agonists or following orchidectomy
    • patients who fail to respond to, or cannot tolerate, alternative treatments
  • liver function tests are conducted before treatment and whenever hepatic impairment is suspected
  • cyproterone is withheld once evidence of hepatotoxicity develops

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page